Abstract:BACKGROUND: Malignant obstructive jaundice is mainly caused by cholangiocarcinoma. Only a few patients are indicated for surgical resection, and the 3-year survival rate is < 50%. For patients who are not eligible for surgery, biliary stent placement can relieve biliary obstruction and improve liver function and quality of life. However, restenosis after biliary stents has a poor prognosis and is a clinical challenge. Biliary stent combined with iodine-125 (125I) seed implantation can prolong stent patency and improve survival.AIM: To evaluate the safety and efficacy of biliary stent combined with 125I seed strand implantation in malignant obstructive jaundice.METHODS: We enrolled 67 patients between January 2016 and June 2018 with malignant obstructive jaundice and randomized them into a biliary stent combined with 125I seed strand treatment (combined) group (n = 32) and biliary stent (control) group (n = 35). All patients underwent enhanced computed tomography and magnetic resonance imaging and were tested for biochemical and cancer markers. Twelve patients underwent pathological examination before surgery. All patients were followed up by telephone or clinical visit. Postoperative liver function improvement, postoperative complications, stent patency time, and survival time were compared between the two groups. Prognostic risk factors were evaluated.RESULTS: Technical success was achieved in all patients in both groups. Postoperative liver function improved significantly in all patients (total bilirubin, direct bilirubin, alanine aminotransferase, and aspartate aminotransferase decreased significantly in all patients, the P values were less than 0.05). There was no significant difference in preoperative or postoperative indexes between the two groups for changes in total bilirubin (P = 0.147), direct bilirubin (P = 0.448), alanine aminotransferase (P = 0.120), and aspartate aminotransferase (P = 0.387) between the two groups. The median stent patency time of the combined group was 9.0 ± 1.4 mo [95% confidence interval (CI): 6.3-11.8 mo], which was significantly longer than the that of the control group (6.0 ± 0.3 mo, 95%CI: 5.5-6.5 mo, P = 0.000). The median survival time of the combined group was 11.0 ± 1.4 mo (95%CI: 8.2-13.7 mo), which was significantly longer than that of the control group (7.0 ± 0.3 mo, 95%CI: 6.4-7.6 mo, P = 0.000). Location of obstruction and number of stents were independent risk factors affecting prognosis.CONCLUSION: Biliary stent combined with 125I seed strand implantation is safe and effective in malignant obstructive jaundice and improves stent patency time and median survival time.

Interventional Therapy of Malignant Hilar Biliary Obstructive Jaundice

Percutaneous Drainage and Stenting for Treatment of Malignant Obstruction of Bile Duct

Percutaneous Transhepatic Biliary Drainage and Stenting for Malignant Obstructive Jaundice: A Report of Two Cases

Lately Therapeutic Effect and Impact Factors of Bilateral PTBD in Malignant Hilar Biliary Obstructive Jaundice

Surgical Intervention for Obstructive Jaundice Due to Biliary Tumor Thrombus in Hepatocellular Carcinoma

Interventional Treatment of Hilar Hepatocellular Carcinoma Combined with Obstructive Jaundice

Interventional Therapy for Biliary Obstructive Jaundice of 39 Cases

Hepato-biliary-enteric stent drainage as palliative treatment for proximal malignant obstructive jaundice

Imaging Diagnosis and Interventional Treatment for the Primary Hepatocellular Carcinoma with Biliary Obstruction

Hepatocellular Carcinoma with Bile Duct Thrombi: Analysis of Surgical Treatment.

600 Patients with Malignant Obstructive Jaundice Treated by Percutaneous Transhepatic Cholangial Drainage and Metallic Stent

Surgical Treatment of Obstructive Jaundice Caused by Bile Duct Strictures after Hepatic Transcatheter Arterial Chemoembolization

The Clinical Observation of Interventional Therapy for Malignant Obstructive Jaundice

Percutaneous Transhepatic Biliary Drainage under Fluoroscopic and Ultrasound Guidance for the Treatment of Obstructive Jaundice: Its Clinical Application

Drainage of Malignant Obstructive Jaundice with Minimally Invasive Procedure

Preliminary application of brachytherapy with double-strand 125I seeds and biliary drainage for malignant obstructive jaundice

The Treatment of Obstructive Jaundice Caused by Bile Duct Strictures after Hepatic Transcatheter Arterial Chemoembolization in Liver Tumor Patients

Palliative treatment for obstructive jaundice caused by unresectable malignancies by percutaneous transhepatic insertion of self-expandable metallic stents

[Preliminary Clinical Study of Percutaneous Transhepatic Bipolar Radiofrequency Ablation Catheter in the Treatment for Malignant Biliary Obstructive Jaundice and Biliary Stent Re-Stenosis].

Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice

Ultrasound-guided percutaneous transhepatic biliary drainage for distal biliary malignant obstructive jaundice